Scientists have identified 570 genes that act abnormally during the development of Parkinsons Disease, a finding which could help doctors predict the likelihood of it developing, and provide targets for new treatments.
The research published in Neurogenetics, by the team from Imperial College London and the University of Liege, Belgium, uses microarrays to analyse brains from Parkinsons patients. Microarrays are laboratory chips able to pick out which genes are active when different processes are occurring in the brain. When they analysed brains from people with Parkinsons, they found that out of all 25,000 human genes, regulation of 570 was highly abnormal in Parkinsons brains compared with non-diseased brains. This is the first study on Parkinsons disease where all human genes were studied.
The researchers analysed 23 brains from recently deceased patients, 15 affected by Parkinsons and 8 control brains. The majority of brains were provided by the UK Parkinsons Disease Society Tissue Bank at Imperial College London.
Dr Linda Moran from Imperial College London and one of the authors of the paper, said: "This research shows there are a considerable number of genes associated with the development of Parkinsons, potentially providing new clues for how to treat this disease. Now that we can identify these genes it may be possible to develop new therapies to help the increasing numbers of Parkinsons patients."
The team, led by Professor Manuel Graeber, analysed two parts of the brain which are affected by neurodegeneration in Parkinsons; the substantia nigra in the mid-brain, and the cerebral cortex. They were able to eliminate around 15,000 genes from any role in Parkinsons, as they were not found to be active in the substantia nigra, the part of the brain most affected by Parkinsons.
Dawn Duke, MS, from Imperial College London, and one of the authors of the paper said: "In addition to identifying those genes linked with the development of Parkinsons, this research has also shown that many of these genes were especially active in Parkinsons brains. By limiting the activity of these genes, we may be able to control or even stop the development of Parkinsons."
Tony Stephenson | Source: EurekAlert!
Further information: www.imperial.ac.uk
More articles from Life Sciences:
Scientists watch as peptides control crystal growth with ‘switches, throttles and brakes’
25.11.2009 | DOE/Lawrence Livermore National Laboratory
Arsenic and Gold Clusters
25.11.2009 | Angewandte Chemie International Edition
First black holes may have incubated in giant, starlike cocoons
25.11.2009 | Physics and Astronomy
KfW issues its first ever 7 year Euro-Benchmark
25.11.2009 | Business and Finance
Intelligence inside metal components
25.11.2009 | Information Technology
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News